# Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE)

> **NCT05457491** · PHASE1 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 56 (actual)

## Conditions studied

- Skin Aging

## Interventions

- **BIOLOGICAL:** Human platelet extract (cosmetic product)
- **OTHER:** Vanicream Gentle Facial Cleanser
- **OTHER:** EltaMD UV Daily Broad-Spectrum SPF 40
- **OTHER:** EltaMD PM Therapy Facial Moisturizer
- **OTHER:** Vanicream Lite Lotion

## Key facts

- **NCT ID:** NCT05457491
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Principal Investigator discretion
- **Last updated:** 2024-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05457491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05457491, "Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05457491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*